| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,999 |
8,342 |
$1.69M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,022 |
2,785 |
$1.00M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,272 |
10,603 |
$686K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,165 |
1,100 |
$228K |
| 80053 |
Comprehensive metabolic panel |
12,059 |
10,055 |
$194K |
| 87631 |
|
1,439 |
1,389 |
$158K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,608 |
11,850 |
$124K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,399 |
2,187 |
$124K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,189 |
3,652 |
$122K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,484 |
1,396 |
$108K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,169 |
1,027 |
$72K |
| 71045 |
Radiologic examination, chest; single view |
2,400 |
2,189 |
$52K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,862 |
3,663 |
$51K |
| 76801 |
|
597 |
523 |
$49K |
| 71046 |
Radiologic examination, chest; 2 views |
1,229 |
1,177 |
$43K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
497 |
478 |
$40K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
993 |
886 |
$39K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
239 |
234 |
$35K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
913 |
861 |
$34K |
| 83880 |
|
1,164 |
1,067 |
$29K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
655 |
429 |
$28K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
414 |
399 |
$27K |
| 84484 |
|
2,994 |
2,172 |
$25K |
| 81001 |
|
6,153 |
5,606 |
$19K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
596 |
554 |
$19K |
| 84703 |
|
2,976 |
2,767 |
$15K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
95 |
93 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
181 |
174 |
$13K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,835 |
2,998 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,116 |
1,449 |
$11K |
| 93976 |
|
159 |
143 |
$11K |
| CP007 |
|
250 |
191 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
773 |
732 |
$11K |
| 86850 |
|
560 |
520 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
547 |
421 |
$9K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
82 |
80 |
$9K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,397 |
2,221 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
293 |
277 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
680 |
653 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,985 |
1,270 |
$8K |
| 84702 |
|
995 |
807 |
$8K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
132 |
103 |
$8K |
| 83690 |
|
2,243 |
2,053 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
155 |
89 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
732 |
692 |
$7K |
| 94760 |
|
358 |
249 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
280 |
265 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,824 |
1,603 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
870 |
773 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
267 |
253 |
$6K |
| 83605 |
|
726 |
506 |
$6K |
| 81025 |
|
821 |
791 |
$6K |
| 76830 |
Ultrasound, transvaginal |
56 |
54 |
$6K |
| 83735 |
|
1,359 |
1,000 |
$5K |
| 87634 |
|
80 |
76 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
15 |
14 |
$5K |
| 87040 |
|
695 |
333 |
$5K |
| 85610 |
|
1,763 |
1,521 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
30 |
29 |
$4K |
| 87430 |
|
230 |
222 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
809 |
611 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,165 |
1,556 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
520 |
488 |
$3K |
| 85730 |
|
694 |
620 |
$3K |
| 85379 |
|
411 |
380 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
895 |
775 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
26 |
26 |
$2K |
| 86901 |
|
1,117 |
1,026 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,270 |
2,699 |
$2K |
| 86900 |
|
766 |
602 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
277 |
258 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
13 |
$2K |
| 73560 |
|
36 |
24 |
$1K |
| 96376 |
|
430 |
318 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,012 |
922 |
$1K |
| 84100 |
|
336 |
236 |
$936.50 |
| 86140 |
|
292 |
237 |
$902.84 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
910 |
705 |
$673.97 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
24 |
24 |
$658.71 |
| 85027 |
|
171 |
114 |
$637.01 |
| 73630 |
|
13 |
12 |
$573.17 |
| 81003 |
|
218 |
206 |
$397.95 |
| 84145 |
|
13 |
12 |
$309.72 |
| 82550 |
|
62 |
52 |
$301.48 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
34 |
26 |
$263.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
250 |
230 |
$253.83 |
| 82607 |
|
12 |
12 |
$166.15 |
| 80061 |
Lipid panel |
15 |
13 |
$138.20 |
| 82565 |
|
65 |
58 |
$135.92 |
| 85014 |
|
74 |
58 |
$122.53 |
| 87186 |
|
13 |
13 |
$117.30 |
| 36415 |
Collection of venous blood by venipuncture |
3,619 |
2,930 |
$107.36 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
100 |
79 |
$99.35 |
| J1644 |
Injection, heparin sodium, per 1000 units |
48 |
26 |
$98.03 |
| 86769 |
|
13 |
13 |
$91.75 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
40 |
28 |
$91.38 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
134 |
124 |
$64.86 |
| 87210 |
|
14 |
13 |
$59.37 |
| J2060 |
Injection, lorazepam, 2 mg |
52 |
39 |
$53.07 |
| 85652 |
|
12 |
12 |
$47.76 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
66 |
52 |
$33.95 |
| J2704 |
Injection, propofol, 10 mg |
256 |
216 |
$24.52 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
43 |
37 |
$13.28 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
359 |
339 |
$11.85 |
| 80051 |
|
17 |
14 |
$10.94 |
| 84520 |
|
17 |
14 |
$6.17 |
| 82947 |
|
17 |
14 |
$6.12 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
21 |
17 |
$4.08 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
13 |
12 |
$2.62 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
15 |
14 |
$2.55 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
41 |
39 |
$1.95 |
| A9270 |
Non-covered item or service |
3,912 |
3,034 |
$0.00 |